$73.74
-2.80-3.66%
À la fermeture: -
$74.20
0.460.62%
Après les heures de négociation: 7:57 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
e.l.f. Beauty Inc a un objectif de cours consensuel de $130.06 basé sur les évaluations de 16 analystes. Le plus élevé est $170, publié par Morgan Stanley le octobre 8, 2025. Le plus bas est $75, publié par DA Davidson le mars 19, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par Goldman Sachs, JP Morgan et Jefferies le novembre 7, 2025, novembre 6, 2025 et novembre 6, 2025, respectivement. Avec un objectif de cours moyen de $130.67 entre Goldman Sachs, JP Morgan et Jefferies, il existe une variation implicite de 76.10% upside pour e.l.f. Beauty Inc selon ces dernières évaluations d’analystes.
Sociétés d'analyse émettant des recommandations1
Goldman Sachs
JP Morgan
Jefferies
Canaccord Genuity
UBS
1calculé à partir des notes des analystes
Notes d'analystes pour e.l.f. Beauty
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/07/2025 | 81.94% | Goldman Sachs | $155 → $135 | Maintains | Buy | |||
11/06/2025 | 84.64% | JP Morgan | $168 → $137 | Maintains | Overweight | |||
11/06/2025 | 61.73% | Jefferies | $150 → $120 | Maintains | Buy | |||
11/06/2025 | 83.29% | Canaccord Genuity | $165 → $136 | Maintains | Buy | |||
11/06/2025 | 41.51% | UBS | $150 → $105 | Maintains | Neutral | |||
11/06/2025 | 68.46% | Baird | $145 → $125 | Maintains | Outperform | |||
11/06/2025 | 34.77% | Piper Sandler | $150 → $100 | Downgrade | Overweight → Neutral | |||
10/28/2025 | 102.16% | Jefferies | $135 → $150 | Maintains | Buy | |||
10/21/2025 | 122.37% | Canaccord Genuity | $165 → $165 | Maintains | Buy | |||
10/20/2025 | 122.37% | Raymond James | $155 → $165 | Maintains | Strong Buy | |||
10/10/2025 | 126.42% | JP Morgan | $130 → $168 | Maintains | Overweight | |||
10/08/2025 | 102.16% | UBS | $112 → $150 | Maintains | Neutral | |||
10/08/2025 | 129.11% | Morgan Stanley | $134 → $170 | Maintains | Overweight | |||
10/02/2025 | 108.89% | Goldman Sachs | $137 → $155 | Maintains | Buy | |||
09/17/2025 | 115.63% | B of A Securities | $135 → $160 | Maintains | Buy | |||
09/10/2025 | 115.63% | B. Riley Securities | $150 → $160 | Maintains | Buy | |||
09/08/2025 | 108.89% | Raymond James | $140 → $155 | Reiterates | Strong Buy → Strong Buy | |||
09/04/2025 | 102.16% | Piper Sandler | → $150 | Assumes | → Overweight | |||
09/02/2025 | 72.51% | Deutsche Bank | $121 → $128 | Downgrade | Buy → Hold | |||
08/11/2025 | 80.59% | Morgan Stanley | $114 → $134 | Upgrade | Equal-Weight → Overweight | |||
08/07/2025 | 72.51% | Canaccord Genuity | $150 → $128 | Maintains | Buy | |||
08/07/2025 | 75.2% | JP Morgan | $132 → $130 | Maintains | Overweight | |||
08/07/2025 | 50.94% | UBS | $120 → $112 | Maintains | Neutral | |||
08/07/2025 | 84.64% | Goldman Sachs | $120 → $137 | Maintains | Buy | |||
08/07/2025 | 53.64% | Morgan Stanley | $105 → $114 | Maintains | Equal-Weight | |||
07/25/2025 | 77.9% | JP Morgan | $123 → $132 | Maintains | Overweight | |||
07/17/2025 | 61.73% | UBS | $95 → $120 | Maintains | Neutral | |||
07/09/2025 | 102.16% | Canaccord Genuity | $114 → $150 | Maintains | Buy | |||
06/20/2025 | 81.94% | B of A Securities | $113 → $135 | Maintains | Buy | |||
06/13/2025 | 102.16% | B. Riley Securities | $110 → $150 | Maintains | Buy | |||
06/06/2025 | 75.2% | Truist Securities | $125 → $130 | Maintains | Buy | |||
06/06/2025 | 95.42% | Baird | $110 → $145 | Maintains | Outperform | |||
06/02/2025 | 75.2% | Raymond James | $105 → $130 | Maintains | Strong Buy | |||
05/30/2025 | 68.46% | Truist Securities | $75 → $125 | Maintains | Buy | |||
05/30/2025 | 65.77% | JP Morgan | $70 → $123 | Maintains | Overweight | |||
05/29/2025 | 52.29% | B of A Securities | $95 → $113 | Maintains | Buy | |||
05/29/2025 | 41.51% | Raymond James | $95 → $105 | Maintains | Strong Buy | |||
05/29/2025 | 46.9% | Piper Sandler | $81 → $109 | Maintains | Overweight | |||
05/29/2025 | 41.51% | Morgan Stanley | $70 → $105 | Maintains | Equal-Weight | |||
05/29/2025 | 54.99% | Jefferies | $75 → $115 | Maintains | Buy | |||
05/29/2025 | 53.64% | Canaccord Genuity | $105 → $114 | Maintains | Buy | |||
05/22/2025 | 28.03% | Raymond James | $85 → $95 | Maintains | Strong Buy | |||
05/21/2025 | 13.21% | UBS | $59 → $84 | Maintains | Neutral | |||
05/21/2025 | 28.03% | B of A Securities | $80 → $95 | Maintains | Buy | |||
05/14/2025 | 34.77% | Baird | $85 → $100 | Maintains | Outperform | |||
04/30/2025 | 9.16% | Piper Sandler | $90 → $81 | Maintains | Overweight | |||
04/24/2025 | 1.08% | Truist Securities | $100 → $75 | Maintains | Buy | |||
04/23/2025 | 1.08% | Jefferies | $175 → $75 | Maintains | Buy | |||
04/17/2025 | -20.49% | UBS | $74 → $59 | Maintains | Neutral | |||
04/17/2025 | 14.56% | Raymond James | $120 → $85 | Maintains | Strong Buy | |||
04/14/2025 | 14.56% | Baird | $110 → $85 | Maintains | Outperform | |||
04/11/2025 | -5.66% | JP Morgan | $127 → $70 | Maintains | Overweight | |||
03/31/2025 | 21.29% | Piper Sandler | $102 → $90 | Maintains | Overweight | |||
03/19/2025 | 1.08% | DA Davidson | $75 → $75 | Maintains | Neutral | |||
03/17/2025 | 1.08% | DA Davidson | $80 → $75 | Maintains | Neutral | |||
02/21/2025 | 67.12% | Goldman Sachs | $142 → $124 | Maintains | Buy | |||
02/18/2025 | 7.82% | DA Davidson | $80 → $80 | Maintains | Neutral | |||
02/07/2025 | 48.25% | Baird | $175 → $110 | Maintains | Outperform | |||
02/07/2025 | 48.25% | Jefferies | $175 → $110 | Maintains | Buy | |||
02/07/2025 | 41.51% | Canaccord Genuity | $174 → $105 | Maintains | Buy | |||
02/07/2025 | 91.37% | Goldman Sachs | $165 → $142 | Maintains | Buy | |||
02/07/2025 | 21.29% | B. Riley Securities | $150 → $90 | Reiterates | Buy → Buy | |||
02/07/2025 | 61.73% | Raymond James | $175 → $120 | Maintains | Strong Buy | |||
02/07/2025 | 14.56% | Stifel | $105 → $85 | Maintains | Hold | |||
02/07/2025 | 37.47% | Piper Sandler | $131 → $102 | Reiterates | Overweight → Overweight | |||
02/07/2025 | 7.82% | DA Davidson | $170 → $80 | Downgrade | Buy → Neutral | |||
02/07/2025 | -0.27% | UBS | $158 → $74 | Downgrade | Buy → Neutral | |||
02/07/2025 | -5.66% | Morgan Stanley | $153 → $70 | Downgrade | Overweight → Equal-Weight | |||
02/05/2025 | 76.55% | Piper Sandler | $167 → $131 | Maintains | Overweight | |||
02/05/2025 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
02/03/2025 | 41.51% | Stifel | $115 → $105 | Maintains | Hold | |||
01/31/2025 | 134.5% | Canaccord Genuity | $200 → $174 | Maintains | Buy | |||
01/21/2025 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
01/16/2025 | 112.94% | UBS | $156 → $158 | Maintains | Buy | |||
01/16/2025 | 119.68% | JP Morgan | $154 → $163 | Maintains | Overweight | |||
01/13/2025 | 106.2% | Morgan Stanley | $139 → $153 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | 125.07% | Piper Sandler | $165 → $167 | Maintains | Overweight | |||
12/23/2024 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
12/19/2024 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
12/18/2024 | 102.16% | Truist Securities | $130 → $150 | Maintains | Buy | |||
12/13/2024 | 122.37% | Goldman Sachs | → $165 | Initiates | → Buy | |||
12/12/2024 | 79.25% | Deutsche Bank | → $133 | Initiates | → Hold | |||
12/11/2024 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/29/2024 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/25/2024 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/12/2024 | 129.11% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/07/2024 | 54.99% | Stifel | $131 → $115 | Maintains | Hold | |||
11/07/2024 | 102.16% | B. Riley Securities | $175 → $150 | Maintains | Buy | |||
11/07/2024 | 169.54% | Canaccord Genuity | $250 → $200 | Maintains | Buy | |||
11/07/2024 | 107.55% | JP Morgan | $167 → $154 | Maintains | Overweight | |||
11/07/2024 | 122.37% | Piper Sandler | $162 → $165 | Reiterates | Overweight → Overweight | |||
11/07/2024 | 129.11% | DA Davidson | $223 → $170 | Maintains | Buy | |||
10/30/2024 | 135.85% | Jefferies | $220 → $175 | Maintains | Buy | |||
10/29/2024 | 200.54% | DA Davidson | $223 → $223 | Maintains | Buy | |||
10/24/2024 | 76.55% | Stifel | $161 → $131 | Maintains | Hold | |||
10/21/2024 | 135.85% | Baird | $240 → $175 | Maintains | Outperform | |||
10/16/2024 | 75.2% | Truist Securities | $210 → $130 | Maintains | Buy | |||
10/15/2024 | 122.37% | B of A Securities | $190 → $165 | Maintains | Buy | |||
10/15/2024 | 200.54% | DA Davidson | $223 → $223 | Maintains | Buy | |||
10/11/2024 | 125.07% | JP Morgan | $207 → $167 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action e.l.f. Beauty (ELF) ?
Le dernier objectif de prix pour e.l.f. Beauty (NYSE:ELF) a été rapporté par Goldman Sachs le novembre 7, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $135.00 s'attendant à ce que ELF se rise dans les 12 prochains mois (un possible changement de 81.94% upside). 86 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour e.l.f. Beauty (ELF) ?
La dernière note d'analyste pour e.l.f. Beauty (NYSE:ELF) a été fournie par Goldman Sachs, et e.l.f. Beauty maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour e.l.f. Beauty (ELF) ?
La dernière amélioration pour e.l.f. Beauty Inc a eu lieu le août 11, 2025 lorsque Morgan Stanley a augmenté leur objectif de prix à $134. Morgan Stanley avait précédemment an equal-weight pour e.l.f. Beauty Inc.
Quand a eu lieu la dernière dégradation pour e.l.f. Beauty (ELF) ?
La dernière réduction pour e.l.f. Beauty Inc a eu lieu le novembre 6, 2025 lorsque Piper Sandler a changé leur objectif de prix de $150 à $100 pour e.l.f. Beauty Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour e.l.f. Beauty (ELF) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de e.l.f. Beauty, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour e.l.f. Beauty a été déposée le novembre 7, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 7, 2026.
La note d'analyste pour e.l.f. Beauty (ELF) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de e.l.f. Beauty (ELF) était un maintenu avec un objectif de prix de $155.00 à $135.00. Le prix actuel de e.l.f. Beauty (ELF) est de $74.20, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.